Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Int J Cardiol ; 245: 114-118, 2017 Oct 15.
Article in English | MEDLINE | ID: mdl-28874282

ABSTRACT

BACKGROUND: Mutations in the genes ENG, ACVRL1 and SMAD4 that are part of the transforming growth factor-beta signalling pathway cause hereditary haemorrhagic telangiectasia (HHT). Mutations in non-HHT genes within this same pathway have been found to associate with aortic dilation. Therefore, we investigated the presence of aortic dilation in a large cohort of HHT patients as compared to non-HHT controls. METHODS: Chest computed tomography of consecutive HHT patients (ENG, ACVRL1 and SMAD4 mutation carriers) and non-HHT controls were reviewed. Aortic root dilation was defined as a z-score>1.96. Ascending and descending aorta dimensions were corrected for age, gender and body surface area. RESULTS: In total 178 subjects (57.3% female, mean age 43.9±14.9years) were included (32 SMAD4, 47 ENG, 50 ACVRL1 mutation carriers and 49 non-HHT controls). Aortopathy was present in a total of 42 subjects (24% of total). Aortic root dilatation was found in 31% of SMAD4, 2% of ENG, 6% of ACVRL1 mutation carriers, and 4% in non-HHT controls (p<0.001). The aortic root diameter was 36.3±5.2mm in SMAD4 versus 32.7±3.9mm in the non-SMAD4 group (p=0.001). SMAD4 was an independent predictor for increased aortic root (ß-coefficient 3.5, p<0.001) and ascending aorta diameter (ß-coefficient 1.6, p=0.04). CONCLUSIONS: SMAD4 gene mutation in HHT patients is independently associated with a higher risk of aortic root and ascending aortic dilation as compared to other HHT patients and non-HHT controls.


Subject(s)
Aortic Diseases/diagnostic imaging , Aortic Diseases/genetics , Mutation/genetics , Smad4 Protein/genetics , Telangiectasia, Hereditary Hemorrhagic/diagnostic imaging , Telangiectasia, Hereditary Hemorrhagic/genetics , Adult , Aorta/diagnostic imaging , Aortic Diseases/epidemiology , Dilatation , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk Factors , Telangiectasia, Hereditary Hemorrhagic/epidemiology
2.
Case Rep Genet ; 2015: 926545, 2015.
Article in English | MEDLINE | ID: mdl-26137330

ABSTRACT

Noninvasive prenatal testing (NIPT) validation studies show high sensitivity and specificity for detection of trisomies 13, 18, and 21. False negative cases have rarely been reported. We describe a false negative case of trisomy 13 and another of trisomy 18 in which NIPT was commercially marketed directly to the clinician. Both cases came to our attention because a fetal anatomy scan at 20 weeks of gestation revealed multiple anomalies. Karyotyping of cultured amniocytes showed nonmosaic trisomies 13 and 18, respectively. Cytogenetic investigation of cytotrophoblast cells from multiple placental biopsies showed a low proportion of nontrisomic cells in each case, but this was considered too small for explaining the false negative NIPT result. The discordant results also could not be explained by early gestational age, elevated maternal weight, a vanishing twin, or suboptimal storage or transport of samples. The root cause of the discrepancies could, therefore, not be identified. The couples involved experienced difficulties in accepting the unexpected and late-adverse outcome of their pregnancy. We recommend that all parties involved in caring for couples who choose NIPT should collaborate to clarify false negative results in order to unravel possible biological causes and to improve the process of patient care from initial counseling to communication of the result.

3.
Haemophilia ; 17(2): 275-81, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21070499

ABSTRACT

The development of neutralizing antibodies against factor VIII (FVIII) is a major complication of treatment with FVIII in patients with severe haemophilia A. This study was designed to describe the relationship between the type and location of the factor 8 (F8) gene mutation and the development of clinically relevant inhibitors in patients with severe haemophilia A. We conducted a single centre cohort study among 318 consecutive patients (baseline FVIII activity level <0.01 IU mL(-1)) born between 1934 and 2007 who were treated with FVIII on at least 50 exposure days. The primary outcome was clinically relevant inhibitor development, defined as the occurrence of at least two positive inhibitor titres and a decreased recovery. Clinically relevant inhibitors were diagnosed in 14% (43) of patients (30 high-titre). The cumulative incidence of inhibitor development was 18% (35 of 200) in high-risk gene defects (67% in patients with large deletions, 30% in patients with nonsense mutations, 15% in patients with intron 1 or 22 inversions) and 7% (8 of 118) in low-risk gene defects (7% in patients with small deletions and insertions, 6% in patients with missense mutations, 8% in patients with splice site mutations). In patients with point mutations, the cumulative risk of developing inhibitors was highest in patients with mutations in the A3 and C2 domains (13% and 17% respectively). In conclusion, in agreement with earlier observations, the type and location of the F8 gene mutation were important determinants of inhibitor development in patients with severe haemophilia A.


Subject(s)
Blood Coagulation Factor Inhibitors/blood , Factor VIII/genetics , Hemophilia A/genetics , Mutation , Adolescent , Adult , Aged , Autoantibodies/blood , Child , Child, Preschool , Cohort Studies , DNA Mutational Analysis , Factor VIII/antagonists & inhibitors , Factor VIII/immunology , Factor VIII/therapeutic use , Genetic Predisposition to Disease , Genotype , Hemophilia A/drug therapy , Hemophilia A/immunology , Humans , Infant , Middle Aged , Phenotype , Risk Factors , Young Adult
4.
J Med Genet ; 43(10): 793-7, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16613914

ABSTRACT

BACKGROUND: Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disease exhibiting multifocal vascular telangiectases and arteriovenous malformations. The majority of cases are caused by mutations in either the endoglin (ENG) or activin receptor-like kinase 1 (ALK1, ACVRL1) genes; both members of the transforming growth factor (TGF)-beta pathway. Mutations in SMAD4, another TGF-beta pathway member, are seen in patients with the combined syndrome of juvenile polyposis (JP) and HHT (JP-HHT). METHODS: We sought to determine if HHT patients without any apparent history of JP, who were undergoing routine diagnostic testing, would have mutations in SMAD4. We tested 30 unrelated HHT patients, all of whom had been referred for DNA based testing for HHT and were found to be negative for mutations in ENG and ALK1. RESULTS: Three of these people harboured mutations in SMAD4, a rate of 10% (3/30). The SMAD4 mutations were similar to those found in other patients with the JP-HHT syndrome. CONCLUSIONS: The identification of SMAD4 mutations in HHT patients without prior diagnosis of JP has significant and immediate clinical implications, as these people are likely to be at risk of having JP-HHT with the associated increased risk of gastrointestinal cancer. We propose that routine DNA based testing for HHT should include SMAD4 for samples in which mutations in neither ENG nor ALK1 are identified. HHT patients with SMAD4 mutations should be screened for colonic and gastric polyps associated with JP.


Subject(s)
Smad4 Protein/genetics , Telangiectasia, Hereditary Hemorrhagic/genetics , Activin Receptors, Type II/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Antigens, CD/genetics , DNA Mutational Analysis , Endoglin , Genetic Testing , Humans , Intestinal Polyps/genetics , Middle Aged , Mutation , Polyps/genetics , Receptors, Cell Surface/genetics
5.
J Med Genet ; 43(4): 371-7, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16155196

ABSTRACT

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterised by vascular malformations in multiple organ systems, resulting in mucocutaneous telangiectases and arteriovenous malformations predominantly in the lungs (pulmonary arteriovenous malformation; PAVM), brain (cerebral arteriovenous malformation; CAVM), and liver (hepatic arteriovenous malformation; HAVM). Mutations in the ENG and ALK-1 genes lead to HHT1 and HHT2 respectively. In this study, a genotype-phenotype analysis was performed. A uniform and well classified large group of HHT patients and their family members were screened for HHT manifestations. Groups of patients with a clinically confirmed diagnosis and/or genetically established diagnosis (HHT1 or HHT2) were compared. The frequency of PAVM, CAVM, HAVM, and gastrointestinal telangiectases were determined to establish the genotype-phenotype relationship. The analysis revealed differences between HHT1 and HHT2 and within HHT1 and HHT2 between men and women. PAVMs and CAVMs occur more often in HHT1, whereas HAVMs are more frequent in HHT2. Furthermore, there is a higher prevalence of PAVM in women compared with men in HHT1. In HHT1 and HHT2, there is a higher frequency of HAVM in women. HHT1 has a distinct, more severe phenotype than HHT2. There is a difference in the presence of symptoms between men and women. With these data, genetic counselling can be given more accurately when the family mutation is known.


Subject(s)
Activin Receptors, Type II/genetics , Antigens, CD/genetics , Receptors, Cell Surface/genetics , Telangiectasia, Hereditary Hemorrhagic/diagnosis , Adult , Arteriovenous Malformations/classification , Arteriovenous Malformations/epidemiology , Arteriovenous Malformations/genetics , DNA Mutational Analysis , Endoglin , Female , Genotype , Humans , Male , Middle Aged , Mutation , Phenotype , Sex Factors , Telangiectasia, Hereditary Hemorrhagic/epidemiology , Telangiectasia, Hereditary Hemorrhagic/genetics
6.
Prenat Diagn ; 25(11): 1032-9, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16231311

ABSTRACT

OBJECTIVE: To test whether multiplex ligation-dependent probe amplification (MLPA) can be used for the detection of aneuploidy of chromosomes 13, 18, 21, X, and Y in uncultured amniocytes. METHODS: We performed a prospective study based on 527 amniotic fluid samples. Chromosome copy numbers were determined by analysing the relative amount of PCR product of chromosome-specific MLPA probes. Results were available within 48 h and were compared with those of karyotyping. RESULTS: There were 517 conclusive MLPA tests. In 514 tests, results were concordant with those of karyotyping. There were two cases of 69,XXX triploidy that could not be detected by MLPA and there was one false-positive result. Here, MLPA indicated a 47,XXY fetus, whereas the karyotype was 46,XY. We correctly identified all 23 cases of autosomal trisomy and the single case of monosomy X in samples collected from 16 up to 36 weeks of gestation. In 10 cases (2%), the result was inconclusive owing to an insufficient amount of DNA. CONCLUSION: Sensitivity, specificity, and failure rate of MLPA were comparable to those of FISH and QF-PCR. Aneuploidy screening in uncultured amniocytes by MLPA is feasible in a clinical diagnostic setting, yielding an informative and rapid result in 98% of cases.


Subject(s)
Amniocentesis/methods , Amniotic Fluid/cytology , Aneuploidy , Chromosome Disorders/diagnosis , Genetic Testing/methods , Polymerase Chain Reaction/methods , Chromosomes, Human , False Positive Reactions , Female , Humans , In Situ Hybridization, Fluorescence , Pregnancy , Prospective Studies , Sensitivity and Specificity , Trisomy
7.
Hum Genet ; 116(1-2): 8-16, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15517393

ABSTRACT

Hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease is an autosomal dominant disorder characterized by an aberrant vascular development. The resulting vascular lesions range from smaller mucocutaneous telangiectases to large visceral arteriovenous malformations, especially in the skin, lung, gastrointestinal tract and the brain. Mutations in the genes encoding endoglin (ENG, chromosome 9q34) and activin A receptor type-like kinase 1 (ALK-1, also named ACVRL1, chromosome 12q13) are associated with HHT1 and HHT2, respectively. We report here on the genetic and molecular heterogeneity found in the HHT population in the Netherlands. Probands of 104 apparently unrelated families were studied and we performed sequence analysis on both the ENG gene and ALK-1 gene. In most of the probands, we found a mutation in one of the two genes: 53% in the ENG gene and 40% in the ALK-1 gene. In 7% of the families no ENG or ALK1 mutation was found. The mutations detected were deletions, insertions, nonsense, missense and splice site mutations. The majority were novel mutations.


Subject(s)
Activin Receptors, Type I/genetics , Telangiectasia, Hereditary Hemorrhagic/genetics , Vascular Cell Adhesion Molecule-1/genetics , Activin Receptors, Type II , Amino Acid Sequence , Antigens, CD , DNA Mutational Analysis , Endoglin , Humans , Molecular Sequence Data , Netherlands , Receptors, Cell Surface , Sequence Alignment
8.
Prenat Diagn ; 23(13): 1042-4, 2003 Dec 30.
Article in English | MEDLINE | ID: mdl-14691988

ABSTRACT

OBJECTIVES: To evaluate at what gestational age fetal DNA can reliably be detected at the earliest in maternal plasma. METHODS: We performed consecutive blood sampling in the first trimester of pregnancy in 17 women who were pregnant after in vitro fertilization (IVF) or intrauterine insemination (IUI). DNA was isolated and the Y-chromosome specific SRY was amplified by real-time polymerase chain reaction (PCR). We likewise studied 31 women prior to invasive prenatal diagnosis procedures for test validation purposes. All test results were compared to cytogenetic sex or sex at birth. RESULTS: The earliest SRY detection was at a gestational age of 5 weeks and 2 days. In none of 4 pregnancies ending in a miscarriage was SRY detected. We detected SRY in maternal plasma in 1 of 2 patients (50%) carrying a male fetus at a gestational age of 5 weeks, in 4 of 5 (80%) at a gestational age of 7 weeks, in 4 of 4 (100%) at a gestational age of 9 weeks. In all 7 women pregnant with a male fetus, the correct fetal sex was detected by 10 weeks. In none of the 6 patients who delivered a girl was SRY detected. In the validation group, SRY was detected in 13 of the 13 male, and none of the 18 female fetuses. CONCLUSIONS: We conclude that real-time PCR of the SRY gene promises to be a reliable technique for early fetal sexing in maternal plasma.


Subject(s)
DNA/analysis , Genes, sry/genetics , Gestational Age , Sex Determination Analysis/methods , DNA/blood , Female , Humans , Male , Polymerase Chain Reaction/methods , Pregnancy , Pregnancy Trimester, First/blood , Reproducibility of Results
9.
Ned Tijdschr Geneeskd ; 147(13): 603-5, 2003 Mar 29.
Article in Dutch | MEDLINE | ID: mdl-12701394

ABSTRACT

Wilson disease is an autosomal recessive disorder of copper metabolism. The gene defective in Wilson disease encodes a copper transporting P-type ATPase expressed in the liver. The disturbed export of copper into bile results in accumulation of copper in liver and secondarily in other organs such as the brain. These patients generally present with either hepatic or neurological symptoms.


Subject(s)
Adenosine Triphosphatases/genetics , Adenosine Triphosphatases/metabolism , Copper/metabolism , Hepatolenticular Degeneration/genetics , Brain/metabolism , Hepatolenticular Degeneration/metabolism , Humans , Liver/enzymology , Liver/metabolism , Mutation
10.
Ned Tijdschr Geneeskd ; 146(39): 1828-31, 2002 Sep 28.
Article in Dutch | MEDLINE | ID: mdl-12382367

ABSTRACT

Pyruvate kinase (PK) deficiency is a common cause of hereditary non-spherocytic haemolytic anaemia. It is an autosomal recessive disorder caused by mutations in the gene coding for erythrocyte and liver-type pyruvate kinase (PKLR). So far, more than 130 mutations in this gene have been identified. Clinical symptoms, usually restricted to homozygous and compound-heterozygous individuals, are variable, ranging from neonatal jaundice requiring erythrocyte transfusions to a fully compensated haemolytic anaemia. The exact mechanism of erythrocyte destruction is unknown, however adenosine-triphosphate depletion and an increase in 2,3-disphosphoglycerate are thought to be important. The diagnosis of pyruvate kinase deficiency depends upon the demonstration of low PK enzyme activity. Due to the pitfalls in determining true PK activity, DNA testing is a valuable tool in the diagnosis of pyruvate kinase deficiency. By centralizing the molecular diagnostics of pyruvate kinase deficiency in Utrecht, more care can be provided for the diagnosis, treatment and support of patients.


Subject(s)
Anemia, Hemolytic, Congenital Nonspherocytic/diagnosis , Erythrocytes/enzymology , Pyruvate Kinase/deficiency , Pyruvate Kinase/genetics , Anemia, Hemolytic, Congenital Nonspherocytic/genetics , Computer Simulation , Genetic Testing , Humans , Models, Molecular , Mutation , Pyruvate Kinase/chemistry , Pyruvate Kinase/physiology
11.
J Inherit Metab Dis ; 23(6): 529-47, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11032329

ABSTRACT

Glycerol kinase deficiency (GKD) is an X-linked recessive disorder. There are two types. an isolated form and a complex form. We review the clinical, biochemical and molecular genetic features of GKD. The clinical and biochemical phenotype of isolated GKD may vary from a life-threatening childhood metabolic crisis to asymptomatic adult 'pseudohypertriglyceridaemia', resulting from hyperglycerolaemia. To date 38 patients from 24 families with isolated GKD have been reported. At least 7 of these patients had a metabolic crisis during a catabolic condition. The complex GKD is an Xp21 contiguous gene syndrome involving the glycerol kinase locus together with the adrenal hypoplasia congenita (AHC) or Duchenne muscular dystrophy (DMD) loci or both. Clinical features of a patient with complex GKD depend on the loci that are involved. Approximately 100 patients from 78 families with a complex GKD have been reported. Seventeen patients with complex GKD (AHC-GKD-DMD or AHC-GKD) died in the neonatal period or early childhood because of unrecognized or inappropriate management of adrenal dysfunction. Since the outcome of the crisis in GKD is highly dependent on the physicians' knowledge of the disease, we devised an algorithmic approach to the diagnosis. From molecular genetic investigations of isolated GKD, 7 missense mutations, 2 splice site mutations, I nonsense mutation, 1 Alu Sx insertion and 2 small deletions were reported for isolated GKD in 13 unrelated families. In 4 families consisting of more than one patient with the same biochemical and genetic defect, the phenotypic variability of the isolated GKD was remarkable. The clinical variability in isolated GKD cannot be explained by biochemical or by molecular heterogeneity. Isolated GKD patients showed a tendency towards hypoglycaemia with hyperketonaemia; whether the clinical symptoms of GKD are caused by dysfunction of gluconeogenesis and/or ketolysis needs to be investigated further.


Subject(s)
Glycerol Kinase/genetics , Adrenal Insufficiency/genetics , Amino Acid Sequence , Carbohydrate Metabolism, Inborn Errors/diagnosis , Genetic Linkage , Glycerol/blood , Glycerol/urine , Glycerol Kinase/chemistry , Glycerol Kinase/deficiency , Humans , Infant, Newborn , Molecular Sequence Data , Muscular Dystrophies/genetics , Mutation , Phenotype , X Chromosome
12.
Ned Tijdschr Geneeskd ; 143(45): 2261-5, 1999 Nov 06.
Article in Dutch | MEDLINE | ID: mdl-10578426

ABSTRACT

Within a few years the 80,000 human genes will be identified which will increase our understanding of the genetic aspects of a large number of diseases, not only the relatively rare monogenic diseases but also the more frequent multifactorial diseases such as atherosclerosis, thrombosis and schizophrenia. Pharmacogenomics will lead to particular medication that is tuned to the genetic variations of the patient. Presently this increase in knowledge in the area of DNA diagnosis and genetic counselling will lead to a continuous increase in requests for assays. The possibilities for application will depend on new technological developments such as the DNA array technology and automation. To meet the increasing number of requests for genetic counselling, genetic nurses will have to play an important role. Moreover, collaboration between clinical geneticists and other specialists will have to be further intensified.


Subject(s)
Forecasting , Genetic Counseling/trends , Genetic Therapy/trends , Genetics, Medical/trends , Humans , Workforce
13.
Vopr Med Khim ; 45(4): 346-9, 1999.
Article in Russian | MEDLINE | ID: mdl-10547886

ABSTRACT

The mutation analysis of alpha-galactosidase A gene was carried out in two families with Fabry disease described by us earlier. In the family P. a new point mutation E341K (a G to A transition at position 10,999 of the gene) was identified. The mutation causes a Glu341Lys substitution in alpha-galactosidase A molecule. Another point mutation was identified in a patient from family N. who had unusual unusually high residual activity of alpha-galactosidase A. The mutation was identified as R112C (a C to T transition at position 5233 of alpha-galactosidase A gene) and it caused the Arg112Cys substitution in the enzyme molecule. This mutation was earlier described in Japanese patient with showed a complete loss of enzyme activity. However, in this case the mutation was combined with another mutation Glu66Gln. The relationship between genetic heterogeneity and clinical manifestation of Fabry disease is discussed.


Subject(s)
Fabry Disease/enzymology , Point Mutation , alpha-Galactosidase/genetics , Amino Acid Substitution , Fabry Disease/genetics , Genetic Heterogeneity , Humans , alpha-Galactosidase/chemistry
14.
Clin Chim Acta ; 280(1-2): 81-9, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10090526

ABSTRACT

A large Russian family with multiple cases of Fabry disease in several generations is presented. Fourteen family members were clinico-biochemically examined. Among 12 adult children (19-32 years old) of one couple, five sons manifested angiokeratotic skin lesions and other Fabry symptoms. Biochemical studies including an enzyme assay, the analysis of glycosphingolipid excretion and isoelectric focusing of a patient leukocyte extract allowed us to identify Fabry disease in four affected brothers and to establish the heterozygous status of their mother. The analysis of genomic DNA of four patients and their mother revealed a novel E341K missense mutation caused by a G to A transition (codon 341 GAA-AAA) in the alpha-galactosidase A gene.


Subject(s)
Fabry Disease/ethnology , alpha-Galactosidase/genetics , Adult , Amino Acid Substitution , Child, Preschool , Fabry Disease/enzymology , Fabry Disease/genetics , Female , Humans , Infant , Male , Middle Aged , Pedigree , Russia
15.
Eur J Clin Invest ; 29(1): 68-75, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10092992

ABSTRACT

BACKGROUND: An evaluation of nephron-sparing surgery (NSS) or radical nephrectomy (RN) for treating renal cell carcinoma (RCC) in patients with von Hippel-Lindau disease (VHL) was carried out. METHODS: Between 1976 and 1997, 10 patients with RCC from four VHL families, of whom seven were from one family, were studied by clinical and histopathological examination. Before 1991, three patients were treated using RN, and thereafter five patients were treated using NSS. Two patients were not operated on. RESULTS: RCCs in our patients showed a slow growth rate (on average 0.3 cm year-1), and asymptomatic patients presented with tumours of low-grade malignancy. In all patients, tumours were surrounded by a fibrous pseudocapsule. In 5 out of 17 tumours, pseudocapsular invasion was observed, and three of these five tumours broke through the pseudocapsule. To date, these patients have not shown a less favourable outcome than those without pseudocapsular involvement by tumour growth. Multicentricity of RCC was relatively low (4.6 lesions per kidney). In two of the three RN patients, only a single satellite lesion, in the direct vicinity of a RCC, was found in one kidney. Six tumours (1.8-5.5 cm) were enucleated by NSS. During a mean follow-up of 30 months, renal function in these patients was well preserved. CONCLUSIONS: In our patients, RCCs grew slowly, were of low grade, had a dense fibrous pseudocapsule and were thus good candidates for NSS.


Subject(s)
Carcinoma, Renal Cell/surgery , Disease Management , Kidney Neoplasms/surgery , von Hippel-Lindau Disease/surgery , Adult , Age of Onset , Carcinoma, Renal Cell/complications , Carcinoma, Renal Cell/mortality , Carcinoma, Renal Cell/pathology , Carrier State , Female , Follow-Up Studies , Genetic Predisposition to Disease , Humans , Kidney Neoplasms/complications , Kidney Neoplasms/mortality , Kidney Neoplasms/pathology , Male , Middle Aged , Nephrectomy , Pedigree , Retrospective Studies , von Hippel-Lindau Disease/complications , von Hippel-Lindau Disease/genetics , von Hippel-Lindau Disease/mortality
16.
Am J Med Genet ; 82(5): 436-9, 1999 Feb 19.
Article in English | MEDLINE | ID: mdl-10069717

ABSTRACT

Two male relatives with Fabry disease presented striking differences in clinical symptoms and age of onset. The propositus had retarded statural growth and skeletal dysplasia while his nephew suffered mainly from aggravating acroparesthesia and celiac disease. Fabry disease is an X-linked inborn error of glycosphingolipid metabolism resulting from deficient activity of the lysosomal hydrolase alpha-galactosidase A (alpha-Gal A) enzyme. The alpha-Gal A gene is located at Xq22.1. Efforts to establish genotype-phenotype correlations have been limited because most patients have private mutations. In previous clinical studies performed in families with Fabry disease, marked differences in phenotype are described between affected relatives. This family also demonstrates the difficulty in predicting the clinical phenotype in patients and relatives with the same alpha-Gal A mutation. Furthermore, in the absence of a family history, the diagnosis may be easily missed.


Subject(s)
Fabry Disease/genetics , alpha-Galactosidase/genetics , Adolescent , Adult , Child , Diagnosis, Differential , Eye Abnormalities/genetics , Female , Genotype , Heterozygote , Humans , Male , Mutation , Pedigree , Phenotype , Polymorphism, Restriction Fragment Length , X Chromosome/genetics , alpha-Galactosidase/blood
17.
J Med Genet ; 35(8): 650-6, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9719371

ABSTRACT

Isolated glycerol kinase deficiency (GKD) is an X linked recessive disorder. The clinical and biochemical picture may vary from a childhood metabolic crisis to asymptomatic adult "pseudohypertriglyceridaemia", the result of hyperglycerolaemia. We performed glycerol kinase (GK) gene analysis to study the molecular heterogeneity and genotype-phenotype correlation in eight males from three families with isolated GKD. All patients had hyperglycerolaemia and glyceroluria. Four patients from two families were essentially free of symptoms. Three patients had gastrointestinal symptoms with ketoacidosis or hypoglycaemia or both. One patient had recurrent convulsions as the only acute sign, without evidence that it was correlated with a catabolic state. Fasting tests in two symptomatic patients of family 1 showed hyperketotic states, together with a tendency to hypoglycaemia. The diagnosis was confirmed by a defective 14C-glycerol incorporation into trichloroacetic acid precipitable macromolecules in intact skin fibroblasts. Mutation screening of the GK gene was performed by amplification and direct sequencing of exons using PCR. Three novel mutations were identified: (1) a deletion starting downstream of exon 9, extending to the 3' end of the gene; (2) a nonsense mutation R413X caused by a C1351T transition; and (3) a missense mutation W503R caused by a T1651C transition. In addition, we found differences from the reported sequence: (1) exon 9 actually consists of two exons, which consequently will change the number of GK gene exons from 19 to 20 exons, and (2) nucleotide differences in exon 19. So far, no genotype-phenotype correlation can be established in these GKD families.


Subject(s)
Genetic Heterogeneity , Glycerol Kinase/genetics , Metabolism, Inborn Errors/genetics , Mutation , Amino Acid Sequence , Child , Child, Preschool , Female , Glycerol/metabolism , Glycerol Kinase/deficiency , Humans , Infant , Male , Metabolism, Inborn Errors/enzymology , Molecular Sequence Data , Pedigree
18.
Hum Mutat ; 12(1): 19-26, 1998.
Article in English | MEDLINE | ID: mdl-9633815

ABSTRACT

Hereditary tyrosinemia type 1 (HT1) is a rare metabolic disease caused by a deficient activity of the enzyme fumarylacetoacetase (FAH). To investigate the molecular heterogeneity of tyrosinemia, the geographic distribution and the genotype-phenotype relationship, we have analyzed the FAH genotype of 25 HT1 patients. Mutation screening was performed by PCR amplification of exons 1-14 of the FAH gene, followed by SSCP analysis and direct sequencing of the amplified exons. Fourteen different mutations were found, of which seven were novel, viz. three missense mutations (G158D, P261L, F405H), a deletion of three nucleotides causing a deletion of serine (DEL366S) and three splice site mutations: IVS2+1(g-t), IVS6-1(g-c), IVS8-1(g-c). The splice site mutations IVS6-1(g-t) and IVS12+5(g-a) were frequently found in countries around the Mediterranean and northwestern Europe, respectively. No clear correlation between the genotype and the three major HT1 subtypes could be established.


Subject(s)
Amino Acid Metabolism, Inborn Errors/genetics , Hydrolases/genetics , Mutation , Tyrosine/blood , Amino Acid Metabolism, Inborn Errors/blood , Amino Acid Metabolism, Inborn Errors/epidemiology , Base Sequence , DNA , Europe/epidemiology , Genetic Heterogeneity , Heterozygote , Homozygote , Humans , Mediterranean Region/epidemiology , Polymorphism, Single-Stranded Conformational
19.
J Med Genet ; 33(8): 682-8, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8863162

ABSTRACT

We describe two female monozygotic (MZ) twins heterozygous for Fabry disease, an X linked disorder resulting from the deficient activity of alpha-galactosidase A. While one of the twins was clinically affected, the other was asymptomatic. Enzymatic assay of alpha-galactosidase in blood leucocytes, skin fibroblasts, Epstein-Barr virus transformed lymphoid cell lines, and hair follicles of the twins and their parents confirmed the heterozygous status of the twins and indicated that Fabry disease had occurred as a result of a de novo mutation. The son of the unaffected twin sister was shown to be hemizygous. Molecular analysis of the alpha-galactosidase A gene permitted the identification of an as yet undescribed point mutation at position 10182 of exon 5 which causes an Asp to Asn substitution at codon 231. Single strand conformation polymorphism (SSCP) analysis again showed the heterozygous status of the twins and a normal pattern in their parents. The basis for the discordant expression of this d novo mutation in the twins was investigated by studying their X inactivation status. Analysis of the inactive X specific methylation at the androgen receptor gene showed unbalanced inactivation in the twins' fibroblasts and in opposite directions. While the maternally derived X chromosome was preferentially active in the asymptomatic twin, the paternal X chromosome was active in the other, affected twin and was found in her hemizygotic nephew. These data suggest that the paternal X chromosome carries the de novo alpha-galactosidase A mutation and that uneven X inactivation is the underlying mechanism for disease expression in this novel female MZ twin pair. This is the first documented case of female twins discordant for Fabry disease.


Subject(s)
Dosage Compensation, Genetic , Fabry Disease/genetics , Point Mutation/genetics , Twins, Monozygotic/genetics , alpha-Galactosidase/genetics , Adult , Cells, Cultured , DNA Methylation , Fabry Disease/enzymology , Female , Fibroblasts/enzymology , Genes/genetics , Hair Follicle , Heterozygote , Humans , Leukocytes/enzymology , Male , Molecular Sequence Data , Pedigree , Polymorphism, Single-Stranded Conformational , Receptors, Androgen/genetics , alpha-Galactosidase/metabolism
20.
Hum Hered ; 46(4): 185-90, 1996.
Article in English | MEDLINE | ID: mdl-8807319

ABSTRACT

Single-strand conformational analysis was used to screen for genetic defects in all thirteen exons of the phenylalanine hydroxylase gene (PAH) in phenylketonuria and hyperphenylalaninemia patients in the Netherlands. Exons that showed a bandshift were sequenced directly. In this way, we were able to identify 93% of the PAH mutations in a panel of 34 patients. Twenty-one different mutations were found: 4 of these gene aberrations are novel.


Subject(s)
Mutation , Phenylalanine Hydroxylase/genetics , Phenylketonurias/enzymology , Polymorphism, Single-Stranded Conformational , Amino Acid Metabolism, Inborn Errors/blood , Amino Acid Metabolism, Inborn Errors/enzymology , Amino Acid Metabolism, Inborn Errors/genetics , DNA Mutational Analysis , Exons/genetics , Genetic Heterogeneity , Genotype , Humans , Netherlands , Phenylalanine/blood , Phenylketonurias/blood , Phenylketonurias/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...